For Medical Professionals

Ophthalmologic management

Very important vision saving treatment: The Ophthalmologic Management of Acute Stevens-Johnson Syndrome, By Darren G. Gregory, MD. To view full article, please [click here]

IVIG treatment

If started during the beginning stage of SJS IVIG (immunoglobulin treatment) has been successful in treating some SJS patients. It has shortened the course and limited side effects. Read about IVIG Treatment

Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.

Erythema Multiforme

Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok

Stevens Johnson Syndrome & Toxic Epidermal Necrolysis

Stevens Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are now believed to be variants of the same condition, distinct from erythema multiforme. SJS/TEN is a very rare, acute, serious, and potentially fatal skin reaction in which there is sheet-like skin and mucosal loss. Using current definitions, it is usually, possibly always, caused by medications.

Full article on SJS/TEN. DermNet NZ

Toxic epidermal necrolysis and Stevens-Johnson syndrome

Thomas Harr* and Lars E French

 Prevention of Vulvovaginal Sequelae in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Recurrence and outcomes of Stevens – Johnson Syndrome and Toxic Epidermal Necrolysis in Children  Click here:

Products designed by healthcare professionals

Solace Nutrition is a medical nutrition company founded with the intent to develop clinical nutrition products designed for individuals living with chronic disease. Solace Nutrition is dedicated to provide products that meet the nutritional needs that change throughout the lifecycle of individuals living with a chronic disease.

Brandeis studies evaluate visionary approach to improving eyesight

A novel scleral lens developed in Boston proves clinically beneficial in patients who have failed conventional therapies. To view full article please: [click here].

Burn unit treatment of three Stevens Johnson Syndrome cases with Cryopreserved Allograft

Three cases of Stevens-Johnson syndrome are described. This syndrome is characterized by extensive loss of tffe epidermis and other complications. The cutaneous lesions are similar to second-degree burns in their development, and they benefit from temporary coverage with cryopreserved allografts, as may be performed in a Burns Centre: [click here].

Chronic lung disease following Stevens – Johnson Syndrome:

Stem cell transplantion of ocular surface diseases

Skip to content